Home Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.
 

Keywords :   


Ipsen Announces A Step Forward In The Resupply Of Increlex (Mecasermin [rDNA Origin] Injection) In The U.S.

2014-05-16 10:04:38| foodingredientsonline Home Page

Ipsen Biopharmaceuticals, Inc., the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), today announced that a supply of Increlex (mecasermin [rDNA origin] injection) will be available in the U.S. starting June 2, 2014

Tags: the us step forward

Category:Food and Related Products

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 3A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Post Office sabotaged Horizon probe, says investigator
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
More »